This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Genentech, Inc., University of California, Xenon Pharmaceuticals Inc.. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kirkland, CA (2019)
- Montreal, CA (2021)
Company Filing History:
4 out of 3,302 
1 out of 16,048 
1 out of 110 
Years Active: 2019-2025
Title: Innovations and Contributions of Inventor Liang Zhao
Introduction
Liang Zhao is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in developing therapeutic compounds. With a total of 4 patents, his work focuses on innovative methods for treating various diseases.
Latest Patents
Liang Zhao's latest patents include groundbreaking inventions related to therapeutic compounds and methods of use. One of his notable disclosures involves compounds and methods for treating diseases mediated by TEAD, such as cancer. Another significant invention provides benzene sulfonamides and their pharmaceutically acceptable salts, which serve as sodium channel blockers for pain treatment.
Career Highlights
Throughout his career, Liang Zhao has worked with prominent companies in the pharmaceutical industry. He has been associated with Genentech, Inc. and Xenon Pharmaceuticals Inc., where he has contributed to various innovative projects. His expertise in therapeutic compounds has positioned him as a valuable asset in the field.
Collaborations
Liang Zhao has collaborated with several professionals in his field, including Ramsay Beveridge and Daniel P. Sutherlin. These collaborations have further enhanced his research and development efforts, leading to impactful innovations.
Conclusion
Liang Zhao's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile